Nobel Biocare announced today that Oliver Walker (43) has been appointed Chief Financial Officer and Member of the Executive Committee of Nobel Biocare.
He will take up his role at the beginning of August 2012. Oliver Walker is a senior finance executive with over 17 years of experience in international industrial settings, most of which were in the medtech industry. He brings expertise in leading the finance function of companies in dynamic industries with multi-faceted business models.
Oliver Walker spent seven years as CFO of Sonova, a publicly listed, leading hearing solutions company, and four years as CFO of Stratec Medical Group. Prior to Stratec, he worked for the industrial Von Roll Group in various management positions. Oliver Walker holds a Master of Science in Business Economics from the University of Berne, Switzerland.
Richard Laube, CEO of Nobel Biocare: "Oliver Walker brings significant expertise in finance, operational leadership and building scalable organizations. His strong project management and leadership skills and experience in building medical technology companies will be a great asset to Nobel Biocare as we continue to develop our company."
Saturday, 2 November, 2024